Skip to main content
Multiple Sclerosis Discovery Forum
Inspiring Connections
Utility Navigation
Feedback
Newsletter
RSS
Twitter
User Top Menu
Welcome, guest
Log In
Join
Why Join?
Search form
Search
About Us
Overview
Who We Are
Contact
Fan Mail
How to Cite
News & Future Directions
New Findings
News Briefs
Podcasts
News Synthesis
Essays & Opinions
Blogs
Papers
Editors' Picks
Classic Papers
Archive
Forums
Discussions
Webinars
Professional Resources
Meetings & Events
Past Meetings
Funding Opportunities
Jobs
Member Directory
Bulletin Board
Useful Links
Research Resources
Data Visualizations
Clinical Trials - Public Availability of Results
World Map
MS trials baseline
NMO History
NMO Galaxy
Map of MS Prevalence
Progressive MS Authors Galaxy
Word Cloud
MSLine
Ongoing Clinical Trials in MS
MRI-Related Clinical Trials
RRMS and CIS
Immunopathogenesis of MS
The MS Galaxy
ARR in Placebo Groups
Symptoms Prevalence
Scientific Literature TreeMap
Clinical Trials in MS
Drug-Development Pipeline
Tissue Repositories
MSGene
Animal Models
Clinical Trials
Click Here to Support MSDF
You are here
Home
Most Viewed Papers
GeNeuro Announces the Launch of Phase IIb Proof-of-Concept Study with GNbAC1 in Multiple Sclerosis and Servier Equity Investment
Teva and Active Biotech Announce Completion of Patient Enrollment in Laquinimod Phase III CONCERTO Trial
Features of neuromyelitis optica spectrum disorders with aquaporin-4 and myelin-oligodendrocyte glycoprotein antibodies.
Axial 3D gradient-echo imaging for improved multiple sclerosis lesion detection in the cervical spinal cord at 3T.
Adolescents' experiences on coping with parental multiple sclerosis: a grounded theory study.
[Differential diagnosis of multiple sclerosis with pediatric onset: the experience of the Moscow Division for treatment of children and adolescents with multiple sclerosis.]
Cognitive reserve and patient-reported outcomes in multiple sclerosis.
Long-term effects of fingolimod in multiple sclerosis: The randomized FREEDOMS extension trial.
Initial lymphocyte count and low BMI may affect fingolimod-induced lymphopenia.
Chronic social stress impairs virus specific adaptive immunity during acute Theiler's virus infection.
Acylated and unacylated ghrelin impair skeletal muscle atrophy in mice.
Neurodegeneration in Autoimmune Optic Neuritis Is Associated with Altered APP Cleavage in Neurons and Up-Regulation of p53.
[Importance and treatment of spasticity in multiple sclerosis : Results of the MOVE 1 study].
Does hippotherapy effect use of sensory information for balance in people with multiple sclerosis?
High risk of cardiovascular diseases after diagnosis of multiple sclerosis.
NLRP3 inflammasome induces chemotactic immune cell migration to the CNS in experimental autoimmune encephalomyelitis.
Demyelination reduces brain parenchymal stiffness quantified in vivo by magnetic resonance elastography.
Molecular mimicry in the etiology of autoimmune diseases.
Preparation and characterization of Δ(9)-tetrahydrocannabinol-loaded biodegradable polymeric microparticles and their antitumoral efficacy on cancer cell lines.
Kinetics of Proinflammatory Monocytes in a Model of Multiple Sclerosis and Its Perturbation by Laquinimod.
Pathogenic CD8 T cells in multiple sclerosis and its experimental models.
Pilates exercise training vs. physical therapy for improving walking and balance in people with multiple sclerosis: A randomized controlled trial.
UDP-glucose enhances outward K(+) currents necessary for cell differentiation and stimulates cell migration by activating the GPR17 receptor in oligodendrocyte precursors.
Clinical predictors of disease progression in multiple sclerosis patients with relapsing onset in a nation-wide cohort.
Treatment experience, burden and unmet needs (TRIBUNE) in MS study: results from five European countries.
Pages
« first
‹ previous
…
226
227
228
229
230
231
232
233
234
…
next ›
last »